Viewing Study NCT04128267


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2025-12-25 @ 10:33 PM
Study NCT ID: NCT04128267
Status: TERMINATED
Last Update Posted: 2022-09-19
First Post: 2019-10-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Central Pain Syndrome in Survivors of Head and Neck Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Study Overview

Official Title: Characterization of Central Pain Syndrome in Survivors of Head and Neck Cancer
Status: TERMINATED
Status Verified Date: 2022-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Recruitment/accrual impacted by COVID and technical issues with equipment
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.
Detailed Description: Primary objectives:

* To correlate structural and functional MRI signature with one of three pain phenotypes in head and neck cancer survivors: 1) no pain, 2) central pain, and 3) nociceptive pain.
* To correlate the presence of chronic systemic symptoms with pain phenotype

Exploratory objectives:

\- DNA, RNA, and plasma will be collected for genomic, transcriptomic, and proteomic studies. Results will be vertically integrated along with the results of clinical studies described within this protocol to identify targets for future correlative studies.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: